PSPurnima Singh

Purnima Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Purnima Singh has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of genetic architecture of impaired cognitive disease with coronary artery disease in AllofUS

    by Praveen Hariharan, Tafadzwa Machipisa, Minoo Bagheri, Emelia Asamoah, Purnima Singh, Tess Pottinger

  • Open Access

    Evaluation of Genetic Architecture of Impaired Cognitive Disease With Coronary Artery Disease in AllofUS

    by Praveen Hariharan, Tafadzwa Machipisa, Minoo Bagheri, Emelia Asamoah, Purnima Singh, Tess Pottinger

    Background: While genetic studies have focused on coronary artery disease (CAD) and impaired cognition (IC) separately, understanding the genetic architecture of IC with CAD (ICAD) can provide insight into shared gene-based clinical pathophysiology. Methods: We performed common variant exome wide association (ExWAS, MAF≥1%) on AllofUS (AoU) participants (Age ≥60), with ICAD and compared with CAD, IC. We defined CAD as a history of angina/ ischemic heart disease or having coronary revascularization and IC as mild cognitive impairment/all-cause dementia or impaired memory using ICD/SNOMED codes. We further curated a list of IC (n=230) and CAD (n=420) associated SNVs based on our ExWAS and previous genetic studies to compare traits between IC and CAD SNVs, through phenome-wide association analysis (PheWAS). We used a Bonferroni corrected significance threshold at p < 2·7 x 10-7, and p<1·5X10-5, and suggestive threshold at 10-4 and 2·9 X 10-5, for ExWAS and PheWAS respectively. Findings: We identified rs429358 (APOE, OR:1·35 (1·27-1·45), p=7·1 x 10-21), rs11556505 (TOMM40, OR:1·24 (1·16-1·33), p=3·34 X 10-10), rs6857 (NECTIN2, OR:1·27 (1·19-1·35), p=1·3 x 10-12) and rs112502960 (ZNF652 (novel), OR:1·16 (1·10-1·22), p=9·5 X10-8) to be significantly associated with ICAD. Among shared traits between IC and CAD SNVs, we identified coronary atherosclerosis and hyperlipidemia associated with loci in APOE/APOC1/NECTIN2/ABCA1; hypertension with loci in LAMB2/TSPAN14/ZNF652; and conduction deficits with loci in TREML2/TMEM106B. Interpretation: In the diverse AoU participants, we identified many loci significantly associated with ICAD. Through PheWAS, we identified many cardiometabolic traits (coronary atherosclerosis, hypertension, conduction deficits, and hyperlipidemia) shared by IC and CAD SNVs.


  • Open Access

    Evaluation of Genetic Architecture of Impaired Cognitive Disease With Coronary Artery Disease in AllofUS

    by Praveen Hariharan, Tafadzwa Machipisa, Minoo Bagheri, Emelia Asamoah, Purnima Singh, Tess Pottinger

    Background: While genetic studies have focused on coronary artery disease (CAD) and impaired cognition (IC) separately, understanding the genetic architecture of IC with CAD (ICAD) can provide insight into shared gene-based clinical pathophysiology. Methods: We performed common variant exome wide association (ExWAS, MAF≥1%) on AllofUS (AoU) participants (Age ≥60), with ICAD and compared with CAD, IC. We defined CAD as a history of angina/ ischemic heart disease or having coronary revascularization and IC as mild cognitive impairment/all-cause dementia or impaired memory using ICD/SNOMED codes. We further curated a list of IC (n=230) and CAD (n=420) associated SNVs based on our ExWAS and previous genetic studies to compare traits between IC and CAD SNVs, through phenome-wide association analysis (PheWAS). We used a Bonferroni corrected significance threshold at p < 2·7 x 10-7, and p<1·5X10-5, and suggestive threshold at 10-4 and 2·9 X 10-5, for ExWAS and PheWAS respectively. Findings: We identified rs429358 (APOE, OR:1·35 (1·27-1·45), p=7·1 x 10-21), rs11556505 (TOMM40, OR:1·24 (1·16-1·33), p=3·34 X 10-10), rs6857 (NECTIN2, OR:1·27 (1·19-1·35), p=1·3 x 10-12) and rs112502960 (ZNF652 (novel), OR:1·16 (1·10-1·22), p=9·5 X10-8) to be significantly associated with ICAD. Among shared traits between IC and CAD SNVs, we identified coronary atherosclerosis and hyperlipidemia associated with loci in APOE/APOC1/NECTIN2/ABCA1; hypertension with loci in LAMB2/TSPAN14/ZNF652; and conduction deficits with loci in TREML2/TMEM106B. Interpretation: In the diverse AoU participants, we identified many loci significantly associated with ICAD. Through PheWAS, we identified many cardiometabolic traits (coronary atherosclerosis, hypertension, conduction deficits, and hyperlipidemia) shared by IC and CAD SNVs.


  • Central Interaction of 2-Methoxyestradiol and Lipoxygenase in AngII-Hypertension

    by Shubha R. Dutta, Purnima Singh, Chi Young Song, Ji Soo Shin, Kafait U. Malik

    BACKGROUND: Our previous findings that arachidonic acid-12/15-lipoxygenase (LOX)-generated metabolite 12(S)-HETE contributes to angiotensin II (AngII)-induced hypertension and 17β-estradiol protects from AngII-induced hypertension via its cytochrome P450 (CYP)1B1-generated metabolite 2-methoxyestradiol in the paraventricular nucleus (PVN) in female mice led us to test the hypothesis that 2-methoxyestradiol acts by inhibiting the LOX/12(S)-HETE in the PVN. METHODS: AngII was infused subcutaneously by osmotic pumps for 2 weeks in wild-type, LOX-knockout (LOXKO), and CYP1B1KO female mice. The blood pressure was measured by tail-cuff/radiotelemetry. Adenovirus (Ad)-GFP (green fluorescence protein)-LOX-short hairpin RNA, Ad-GFP-LOX-DNA, 12(S)-HETE, and 2-methoxyestradiol were injected selectively in PVN or intracerebroventricularly. Histological, immunohistochemical, and biochemical techniques were used to determine pathophysiological changes caused by various interventions. RESULTS: AngII-induced hypertension that was exaggerated in CYP1B1KO compared with wild-type mice was minimized by PVN-LOX knockdown with Ad-LOX-short hairpin RNA and restored by PVN-LOX reconstitution with Ad-LOX-DNA in intact-LOXKO mice and exacerbated in ovariectomized-LOXKO mice. Furthermore, intracerebroventricular-12(S)-HETE restored AngII-induced increases in blood pressure, autonomic impairment, neuroinflammation, and renal pathogenesis in intact-LOXKO mice, which were exacerbated in ovariectomized-LOXKO mice. Intracerebroventricular-2-methoxyestradiol that reduced the LOX expression and 12(S)-HETE content in PVN minimized AngII effects mentioned above in ovariectomized-LOXKO mice transduced with intracerebroventricular-Ad-LOX-DNA. CONCLUSIONS: These data suggest that 2-methoxyestradiol protects against AngII-induced hypertension and associated pathogenesis, most likely by inhibiting LOX/12(S)-HETE actions in the PVN of female mice. Therefore, the selective LOX inhibitors or 12(S)-HETE receptor antagonists could be useful in treating hypertension and its pathogenesis in postmenopausal, hypoestrogenic women or females with ovarian failure.


  • Open Access

    Ovariectomy Via 12/15-lipoxygenase Augments Angiotensin II-Induced Hypertension and Its Pathogenesis in Female Mice

    by Shubha R. Dutta, Purnima Singh, Kafait U. Malik

    Background: Ang II (angiotensin II) releases arachidonic acid from tissue phospholipids that is metabolized by 12/15-lipoxygenase (ALOX15), generating 12(S)- and 15(S)-hydroxyeicosatetraenoic acid (HETE), which have been implicated in cardiovascular and renal diseases. In this study, we tested the hypothesis that ovariectomy augments Ang II-induced hypertension and renal pathophysiological changes via ALOX15 activation in female mice. Methods: Ang II (700 ng/kg/min) was infused subcutaneously by osmotic pumps for 2 weeks in intact and ovariectomized wild-type and Alox15 knockout (ALOX15KO) female mice for evaluation of hypertension and associated pathogenesis. Results: Ang II increased blood pressure, impaired autonomic function, and increased renal reactive oxygen species production and plasma 12(S)-HETE level without altering renal function in intact wild-type mice. However, in OVX-wild-type mice with depleted plasma 17β-estradiol, the effects of Ang II on blood pressure, autonomic impairment, renal reactive oxygen species production, and plasma 12(S)- but not 15(S)-HETE was markedly enhanced. In OVX-wild-type mice, Ang II also increased renal alox15 mRNA, urine 12(S)-HETE, water intake, urine output, decreased osmolality, increased urinary excretion of vasopressin prosegment copeptin, protein/creatinine ratio, and caused renal hypertrophy, fibrosis, and inflammation. These effects of Ang II were attenuated in ALOX15KO mice. Conclusions: These data suggest that 17β-estradiol protects against Ang II-induced hypertension and associated pathogenesis in female mice, most likely via inhibition of ALOX15-arachidonic acid derived production of 12(S)-HETE. Therefore, the selective inhibitors of ALOX15 or 12(S)-HETE receptor antagonists could be useful for treating hypertension and its pathogenesis in postmenopausal, hypoestrogenic women, or females with ovarian failure.


  • Open Access

    Ovariectomy Promotes Angiotensin II-induced Renal Dysfunction and Vasopressin Excretion via 12/15-Lipoxygenase

    by Shubha R. Dutta, Purnima Singh, Kafait U. Malik

    ID 51393 Poster Board 312 Hypertension is a major risk factor that contributes to kidney injury in women. While the female sex hormone 17β-estradiol (E2) has been shown to be cardioprotective in experimental models of cardiovascular diseases, E2 replacement therapy in postmenopausal women has been controversial. We have shown previously that ovariectomy (used as a tool to deplete endogenous E2) augments angiotensin (Ang) II-induced increase in blood pressure and plasma level of 12(S)-hydroxyeicosatetraenoic acid (HETE), a major arachidonic acid metabolite produced by 12/15-lipoxygenase (ALOX15). ALOX15 and its arachidonic acid-derived metabolite 12(S)-HETE is implicated in cardiovascular and renal diseases. This study was conducted to investigate the contribution of ALOX15 to Ang II-induced renal dysfunction in intact and ovariectomized (OVX) female mice. Ang II (700 ng/kg/min) infused subcutaneously by osmotic pumps for 2 weeks caused a marked increase in water intake (mL; 10.5±0.64 vs 5.0±0.40), and renal dysfunction as evidenced by increased urine output (mL; 5.06±0.43 vs 1.56±0.15), decreased urine osmolality (mOm/Kg; 1.27±0.04 vs 2.10±0.06) and increased urinary excretion of vasopressin prosegment copeptin (pg/mL; 149.53±3.47 vs 122.13±1.00) measured by ELISA in OVX but not intact (with ovaries intact) wild type (WT) mice (n=4/group, pAlox15 knockout (ALOX15KO) female mice (water intake: 4.0±0.41 and 5.25±0.47; urine output: 1.18±0.11 and 1.00±0.10; urine osmolality: 2.56±0.27 and 1.78±0.07; urinary excretion of copeptin: 122.9±0.56 and 118.03±3.76; n=4/group, p<0.05). Moreover, in OVX-WT mice with depleted plasma E2 (pg/mL; 1.00±0.26 vs 14.71±1.38; n=4, p<0.05, measured by ELISA), the effects of Ang II on renal hypertrophy expressed as total kidney/body weight ratio (mg/g; 12.19±0.55 vs 9.16±0.22; n=6, p<0.05) and reactive oxygen species production measured by increased 2-hydroxyethidium fluorescence on staining with dihydroethidium (arbitrary unit; 16.73±0.63 vs 4.33±0.09, n=4, p<0.05), were also enhanced compared to intact WT mice. These effects of Ang II were attenuated in both intact and OVX-ALOX15KO mice (plasma E2: 13.96±1.75 and 1.29±0.44, kidney/body weight: 9.48±0.18 and 10.10±0.33, reactive oxygen species: 1.55±0.07 and 1.82±0.02). These data suggest that ovariectomy or lack of 17b-estradiol promotes Ang II-induced hypertension and renal dysfunction, most likely by a mechanism dependent on ALOX15/12 (S)-HETE. Therefore, the selective inhibitors of ALOX15 or 12 (S)-HETE receptor antagonists could be useful for treating hypertension and associated pathogenesis in postmenopausal, hypoestrogenic women or females with ovarian failure. Furthermore, it has been reported that that two single-nucleotide polymorphisms in the Alox12 gene, rs9904779 and rs434473 (encoding a replacement of asparagine by serine in the protein), was associated with onset of natural menopause in a small set of white women studied. Therefore, it would be important to explore ALOX15 gene polymorphism further in a larger population of diverse groups of normal aging and pre- and postmenopausal females to determine its impact on the contribution of arachidonic acid-ALOX15 derived 12(S)-HETE in hypertension and its pathogenesis.

  • Public-Private Partnership For Food Security in India Through PM-Poshan Scheme

    by Purnima Singh

    Food, water and shelter are the elementary prerequisite for human survival and their well-being. Food provides the necessary nutrients to fuel the body’s functions; access to adequate quantity of safe and nutritious food is a fundamental human right. However, India still faces challenges in ensuring food security for all its citizens leading to malnutrition, dehydration, and various health issues. Food security in India is a crucial issue that affects millions of people, particularly those living in poverty. The Government has implemented various measures to address this issue, including enactment of the National Food Security Act 2013. Pradhan Mantri Poshan Shakti Nirman (PM-Poshan) earlier known as Mid-Day Meal Scheme is a great measure to tackle the problem of malnutrition among children. The program is based on a multi-sectoral approach involving the health, nutrition and sanitation sectors through community-based monitoring and behaviour change communication. The Government has allocated significant funds for the program and has also partnered with various stakeholders through public-private partnership model (PPPs). Still, there are significant gaps and loopholes in the implementation of these policies. This article brings out the intermediatory role of Akshaya Patra under the PPP Model to overcome the emerging challenges towards the implementation of this scheme.


  • Open Access

    Technology as a Double-Edged Sword: Understanding Life Experiences and Coping With COVID-19 in India

    by Girishwar Misra, Purnima Singh, Madhumita Ramakrishna, Pallavi Ramanathan

    The two waves of COVID-19 in India have had severe consequences for the lives of people. The Indian State-imposed various regulatory mechanisms like lockdowns, encouraged remote work, online teaching in academic institutions, and enforced adherence to the COVID protocols. The use of various technologies especially digital/online technologies not only helped to adapt to the “new normal” and cope with the disruptions in pursuing everyday activities but also to manage one’s well-being. However, the availability and accessibility of digital technologies to various sections of the population were not uniform. This paper reports a series of three studies examining the nature of pandemic stress, the impact of technology use on people’s emotional well-being during turbulent times, and the effects of technology use on psychological resources like resilience, self-efficacy, motivation to work, and emotional well-being. The differences in the residential background (Urban/Rural) and SES (Low/High) in the extent of the use of technology and strength of psychological resources were assessed. The findings indicated that the most common causes of concern included worrying about family, friends, partners, fears of getting and giving the viral infection to someone; frustration and or boredom; and changes in normal sleep patterns. It was noted that technology was a double-edged sword and created barriers as well as opportunities for the people. Also, self-efficacy mediated the relationship between the use of technology and emotional wellbeing. The results have policy implications for building resilient communities in the post COVID period.


  • Open Access

    Detrimental orofacial manifestations of dengue and dengue hemorrhagic fever clinical case series, review of the causes, complications, and vaccine strategies

    by Shubha Ranjan Dutta, Purnima Sing

    It is estimated that there are about 10% of cases that involve oral mucosa in patients with dengue hemorrhagic fever (HF), and even less number of cases in dengue fever (DF) has been reported. This leads to a lack of future investigation. Aims and objectives This review intends to enhance the understanding of the epidemiology, clinical features involving the oral manifestations, and treatment of dengue disease. Design and Methods Several search engines, including PubMed, World Health Organization (WHO), and Pan American Health Organization (PAHO) websites were utilized for the literature search using the terms dengue and dengue shock syndrome.Results Dengue is a major arthropod-borne viral disease of humans. Its presentation is protean and varies from an undifferentiated viral syndrome to viral HF and severe shock. The early diagnosis of the oral manifestations, hemorrhagic, or mucocutaneous, may lead to timely clinical evaluation of the patient with signs and symptoms suggestive of dengue viral infection. Conclusion The specific therapy for dengue infections is still undiscovered. Proper care, including vector control and prevention of mosquito bites, may be beneficial. However, the role of dental professionals and general practitioners is important in identifying the oral manifestations of dengue viral infection and providing specific diagnosis and effective treatment to the patients.


  • Open Access

    2-Methoxyestradiol Ameliorates Angiotensin II–Induced Hypertension by Inhibiting Cytosolic Phospholipase A 2 α Activity in Female Mice

    by Chi Young Song, Purnima Singh, Mustafa Motiwala, Ji Soo Shin, Jessica Lew, Shubha R. Dutta, Frank J. Gonzalez, Joseph V. Bonventre, Kafait U. Malik

    We tested the hypothesis that CYP1B1 (cytochrome P450 1B1)-17β-estradiol metabolite 2-methoxyestradiol protects against Ang II (angiotensin II)–induced hypertension by inhibiting group IV cPLA 2 α (cytosolic phospholipase A 2 α) activity and production of prohypertensive eicosanoids in female mice. Ang II (700 ng/kg per minute, SC) increased mean arterial blood pressure (BP), systolic and diastolic BP measured by radiotelemetry, renal fibrosis, and reactive oxygen species production in wild-type mice ( cPLA 2 α +/+ /Cyp1b1 +/+ ) that were enhanced by ovariectomy and abolished in intact and ovariectomized -cPLA 2 α −/− /Cyp1b1 +/+ mice. Ang II–induced increase in SBP measured by tail-cuff, renal fibrosis, reactive oxygen species production, and cPLA 2 α activity measured by its phosphorylation in the kidney, and urinary excretion of prostaglandin E 2 and thromboxane A 2 metabolites were enhanced in ovariectomized- cPLA 2 α +/+ /Cyp1b1 +/+ and intact cPLA 2 α +/+ /Cyp1b1 −/− mice. 2-Methoxyestradiol and arachidonic acid metabolism inhibitor 5,8,11,14-eicosatetraynoic acid attenuated the Ang II–induced increase in SBP, renal fibrosis, reactive oxygen species production, and urinary excretion of prostaglandin E 2 , and thromboxane A 2 metabolites in ovariectomized- cPLA 2 α +/+ /Cyp1b1 +/+ and intact cPLA 2 α +/+ /Cyp1b1 −/− mice. Antagonists of prostaglandin E 2 and thromboxane A 2 receptors EP1 and EP3 and TP, respectively, inhibited Ang II–induced increases in SBP and reactive oxygen species production and renal fibrosis in ovariectomized- cPLA 2 α +/+ /Cyp1b1 +/+ and intact cPLA 2 α +/+ /Cyp1b1 −/− mice. These data suggest that CYP1B1-generated metabolite 2-methoxyestradiol mitigates Ang II–induced hypertension and renal fibrosis by inhibiting cPLA 2 α activity, reducing prostaglandin E 2 , and thromboxane A 2 production and stimulating EP1 and EP3 and TP receptors, respectively. Thus, 2-methoxyestradiol and the drugs that selectively block EP1 and EP3 and TP receptors could be useful in treating hypertension and its pathogenesis in females.